Effect of Nutri-jelly on Quality of Life in Head and Neck Cancer Patients

NCT ID: NCT01871155

Last Updated: 2013-06-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a novel edible nutritious gel for patients with chewing and swallowing difficulties, Nutri-jelly, is effective in improving the quality of life of head and neck cancer patients while undergoing conventional radiotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* independent variable: continuous Nutri -jelly intake
* dependent variable (outcome): changes in health-related quality of life score

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer Dysphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutri-jelly along with radiotherapy

Continuous intake: orally take 1-3 boxes / day for at least 3 days/ week during radiotherapy

Group Type EXPERIMENTAL

Nutri-jelly

Intervention Type DIETARY_SUPPLEMENT

an edible nutritious gel for chewing and swallowing difficulties 1 box contains 250 ml with 250 kcal

1 serving is considered as food supplement

Radiotherapy only

Receive either definitive (total of 30-35 fractions) or palliative ( total of 10 fractions) radiotherapy with no continuous intake of Nutri-Jelly

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nutri-jelly

an edible nutritious gel for chewing and swallowing difficulties 1 box contains 250 ml with 250 kcal

1 serving is considered as food supplement

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed as head and neck cancer
* definitive or palliative radiotherapy treatment plan
* can communicate well

Exclusion Criteria

* bleeding in the mouth
* respiratory distress
* psychiatric disorders
* radiation field not involve masticatory and swallowing apparatus e.g. certain cases of laryngeal cancer and brain cancer
Minimum Eligible Age

35 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Thammasat University

OTHER

Sponsor Role collaborator

Srinakharinwirot University

OTHER

Sponsor Role collaborator

Mahidol University

OTHER

Sponsor Role collaborator

Ministry of Health, Thailand

OTHER_GOV

Sponsor Role collaborator

Dental Innovation Foundation Under Royal Patronage

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dunyaporn Trachootham, DDS, PhD

Role: STUDY_CHAIR

Faculty of Dentistry, Thammasat University, Thailand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mahavachiralongkorn cancer hospital

Pathum Thani, Changwat Pathum Thani, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Related Links

Access external resources that provide additional context or updates about the study.

http://www.dent-in-found.org/

Dental Innovation Foundation under royal patronage, His Majesty the King's dental service unit

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DIF-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.